(DE3) without any overexpression plasmids and Photorhabdus strains (Supplementary Table 7 ) used in this study were cultivated in liquid or solid Luria-Bertani (LB, pH 7.0) medium at 30°C. All E. coli BL21 (DE3) strains with different overexpression plasmids (Supplementary Table 5 ) were cultivated in a standard cultivation condition for protein expression (method described below). The cultivation condition for construction of Photorhabdus luminescens mutants was described below. Chloramphenicol (34 µg mL -1 ), ampicillin (100 µg mL -1 ), kanamycin (50 µg mL -1 ), streptomycin (50 µg mL -1 ) and rifampicin (50 µg mL -1 ) were used for the selection of strains with corresponding resistant markers. For cultivation of E. coli strain ES16 in 15 N or 13 C labeled medium, ISOGRO-15 N or ISOGRO- 13 C medium was prepared according to manufacturer´s instructions (Sigma-Aldrich). Isopropyl-β-D-1-thiogalactopyranoside (IPTG, 0.1 mM) was used to induce the heterologous expression of ant genes in E. coli BL21 (DE3).
General methods in molecular biology. All methods used in molecular biology were conducted according to standard procedures and manufacturer´s instructions. All oligonucleotides (primers) obtained from Sigma-Aldrich were listed in Supplementary   Table 4 . All Plasmids constructed in this work were confirmed by sequencing at the SeqIT GmbH (Germany, Kaiserslautern) also listed in Supplementary Table 5 .
Polymerase chain reactions (PCRs) were performed using the phusion high-fidelity polymerase (Thermo-scientific). DNA isolation was performed with GeneJET™ Gel Extraction Kit (Fermentas). Plasmid isolation was performed with GeneJET™ Plasmid Miniprep Kit (Fermentas). Transformation of plasmids into E. coli was carried out using electroporation protocol for E. coli in an electroporation cuvette with a width of 1 mm (1250V, 25 µF, 200Ω). Genomic DNA was isolated using Gentra® Puregene® kit (Qiagen) according to the protocol for Gram-negative bacteria. Plasmid ZQ80 was constructed using an artificial gene (synthesized by Life Technologies™) flanked with restriction sited EcoRI/PstI.
Construction of E. coli strains with different combinations of ant genes. Two strategies were used to combine different ant genes in this work. The first one is the combination of pJET1.2/blunt and pSU18 based plasmids. The second one is the Table 5 . The plasmid pSUmtaA was described previously. 1 All generated plasmids were selectively transformed into E. coli DH10B for heterologous expression, yielding strains listed in Supplementary Table 6 . The polyketides found in the bacteria culture were listed in Supplementary Table 1 .
Cloning, expression, purification, crystallization and structure determination of His 6 -AntI His 6 -AntI (Photorhabdus luminescens, Uniprot: Q7MZT8, expression vector ZQ40 [Supplementary Table 5 ]) was heterologously expressed in E. coli BL21(DE3) gold. Cells were grown in 6 liter LB-cultures in the presence of kanamycin (50 mg/L) at 37°C. Protein production was induced at an OD 600 of 0.6 by the addition of IPTG to a final concentration of 1 mM. Subsequently, cultures were incubated overnight at 20°C. Cells were harvested by centrifugation and stored at -20°C until further use.
SeMet-labeled protein was expressed in the same strain using a protocol previously described 2 .
For protein purification, cell pellets were resuspended in buffer A (50 mM tris hydrochloride, 500 mM NaCl, pH 7.5) and 20 mM imidazole. Cell disruption was carried out by sonication (Branson Digital Sonifier 250, G. Heinemann, Schwäbisch Gmünd, Germany). The resulting suspension was centrifuged at 30,000 g for 30 min at 4°C using a SIGMA 4K15 centrifuge (Sigma Aldrich, Germany). The supernatant was applied to a 5 mL HisTrap TM HP column (GE Healthcare Life Science, Uppsala, Sweden), which had been equilibrated with buffer A (flow rate, 5 mL/min) using an ÄKTA prime plus system (GE Healthcare, Uppsala, Sweden). The column was washed with 50 mL of buffer A containing 50 mM imidazole. Next, the protein was eluted with buffer A containing 200 mM imidazole. Fractions were combined, concentrated and directly applied to a HiLoad TM 16/60 Superdex TM 200 column (GE Healthcare, Uppsala, Sweden), which had been equilibrated with 20 mM Tris pH 7.5, 100 mM NaCl, 1 mM dithiothreitol (DTT). The obtained peak fractions were analysed by SDS PAGE, pooled and concentrated to a final concentration of 10 mg/mL using Amicon Ultra Centrifugal Filter Device (Millipore, Billerica, USA). Protein not directly applied to crystallographic experiments was flash frozen with liquid nitrogen and stored at -80°C.
Native and SeMet labeled His 6 -AntI crystals were grown by the sitting drop vapor diffusion method at 20°C combining 0.2 µL protein (10 mg/mL in 20 mM Tris pH 7.5, 100 mM NaCl, 5 mM DTT) and 0.2 µL reservoir (0.1 M NaAc, 0.1 M HEPES pH 7.5, 22% PEG3350). Mountable crystals grew within one week. Native diffraction datasets were collected up to 1.85 Å resolution using synchrotron radiation at the X06SA-beamline, SLS, Villigen, Switzerland (see Supplementary Table 3 ). Recorded reflections were processed with the program package XDS 3 . His 6 -AntI crystallized in the orthorhombic space group C222 1 with cell parameters of a = 54 Å, b = 154 Å, c = 91 Å, indicating one AntI-subunit in the asymmetric unit with a solvent content of 41%.
Experimental phases were obtained by single anomalous dispersion (SAD) methods using the peak absorption wavelength of selenium derivatized AntI crystal (λ = 0.9798 Å, f' = -8.05; f'' = 5.52). The program package SHELXD 4 located 10 heavy atom sites using a dataset recorded to 1.9 Å resolution. Subsequent SHARP-SAD-phasing 5 and solvent flattening with the program DM 6 resulted in an electron density map with phases at about 2.5 Å resolution. The quality was sufficient to model secondary structure elements by polyalanine residues. The initial model was transferred to the native dataset with a resolution of 1.85 Å by applying rigid body-and preliminary positional-refinement using REFMAC5 7 . The resulting electron density map allowed unambiguous identification of the entire AntI-sequence. The model was completed in iterative rounds with the three-dimensional graphic programs MAIN 8 and COOT 9 .
Temperature factors were anisotropically refined with restraints between bonded atoms using translation / libration / screw motion-parameters, yielding crystallographic values of R cryst = 0.168 and R free = 0.204 (see Supplementary Table 3 ). Coordinates were confirmed to have superb stereochemistry in the Ramachandran plot with 98.1% of residues in the most favored region and 1.9% of residues in the additionally allowed regions. The asymmetric unit cell contains one AntI subunit with the six N-terminal and the three C-terminal amino acid residues being structurally disordered.
Heterologous expression of genes in E. coli BL21 (DE3): for mutagenesis of AntI.
ZQ40_S245A, ZQ40_D326A, ZQ40_D327A and ZQ40_H355A harboring the mutated gene antI*, were generated (Supplementary Table 5 ). The site-directed mutation was achieved by ligation of two amplified PCR fragments, using the designed primer pair binding around the mutated region (Supplementary Table 4 Table 5 ). Plasmid ZQ62 encoding AntDEFGH and Plasmid ZQ76 encoding AntABC (described above) were used for coexpression with plasmid ZQ80 in E. coli, resulting in strain ES65 in Supplementary Table 6. DNA sequence of the synthesized artificial gene encoding ketoreductase RED1 from the actinorhodin biosynthesis (actVI-ORF1): Analysis of polyketides in bacteria culture by HPLC-MS. For production analysis, extracts from 10 ml of culture were prepared. Usually, 1 % overnight pre-culture was used for inoculation and 2 % AMBERLITE™ XAD-16 (Sigma Aldrich) was added at the same time for the absorption of hydrophobic secondary metabolites. AMBERLITE™ XAD-16 resin beads were collected with a sieve (or filter paper) after 72 h, washed with small amount of water and extracted with 20 mL of methanol. The methanol extract was dried and dissolved in 1 mL methanol, which could be then diluted (1:10-dilution) for the analysis in HPLC-MS. Additionally, the remaining bacteria culture without AMBERLITE™ XAD-16 and bacteria cells was extracted using 10 mL ethyl acetate/acetic acid (99:1). After remove of all the solvent, the dried extract was dissolved in 1 mL methanol, which could be then diluted (1:10-dilution) for the analysis in HPLC-MS.
Analysis of extracts was performed on Dionex ULTIMATE 3000 HPLC system with a photodiode array detector in the range of 200-600 nm and an Acquity UPLC BEH C18 column (1.7 µm, Waters), which is coupled to Bruker AmaZon X iontrap mass spectrometer using electrospray ionization at positive and negative mode. Synthesis of ii. 565 mg of methyl ester i (2.7 mmol, 1 equiv.) were dissolved in 8.5 ml of dry toluene under nitrogen. The mixture was then cooled down to -78°C and 2.8 ml of Me 3 Al in hexane (2M, 2.8 mmol, 1.03 eq.) was added. 1.55 g of tert-butyl((1-methoxyvinyl)oxy)dimethylsilane (7.57 mmol, 2.83 equiv.) were dissolved in 2 ml of toluene. This solution was slowly added to the reaction mixture. The mixture was warmed to 0°C and stirred for 7 hours. The mixture was quenched with 100 ml of saturated aqueous solution of NaHCO 3 , and then extracted 3 times with 30 ml of Synthesis of iii. 160 mg of ii was dissolved in 16 ml of MeOH, and 8 ml of HCl 6M
were added at 0°C. The mixture was stirred 30 min at 0°C then the ice bath was removed and the mixture was stirred for 1 hour at room temperature. The mixture was quenched with 100 ml of NaHCO 3 and extracted three times with 25 ml of AcOEt. The organic layers were combined, washed with brine and dried over Na 2 SO4. The solvents were removed under vacuum and the crude was purified by flash chromatography. The expected compound iii (63 mg) was obtained as yellow oil with a yield of 60%. 1 Multiple sequence alignments of hydrolases. All performed multiple sequence alignments were calculated using the ClustalW-algorithm 12 applying the standard parameters.
Molecular dynamics (MD) simulations. Classical molecular dynamics (MD)
simulations were performed with compound 1 modelled in different poses into the crystal structure of the apo-form of AntI. The ligand-protein system was solvated and neutralized in a water-ion box with a 150 mM KCl concentration, comprising in total ca. 59,000 atoms. The CHARMM36 force field 13 DFT calculations. DFT models were built based on classically relaxed structures of the substrate:AntI complex. The DFT models comprised the aromatic rings of the substrate and the S-acyl moiety of its PPT-arm, the sidechains of protein residues Ser245, Arg24, Asp175, Asp287, Leu284, Ile328, His355, and the backbone atoms of residues Phe246 and Leu174 that form the putative oxyanion-hole. Sidechains were cut at the Cα-Cβ bond, except for the arginine, which was cut at the Cγ-Cδ position, and saturated with hydrogen atoms. The DFT models comprised ca. 140 atoms. The terminal parts of the protein residues were kept fixed during optimizations to simulate the constrains arising from the rigid protein framework. Geometry optimizations were performed at the B3LYP-D3/def2-SVP/ε=10 [17] [18] [19] [20] [21] , and single point energy evaluations were performed at B3LYP-D3/def2-TYZVP with ε=10 and ε=4. Reaction pathways were optimized using a chain-of-states method 22 [a] Asymmetric unit [b] The values in parentheses for resolution range, completeness, R merge and I/σ (I) correspond to the highest resolution shell [c] Data reduction was carried out with XDS and from a single crystal. * Friedel pairs were treated as identical reflections; # Friedel pairs were treated as individual reflections [d] R merge (I) = Σ hkl Σ j | I(hkl) j -<I(hkl)> | / Σ hkl Σ j I(hkl) j , where I(hkl) j is the j th measurement of the intensity of reflection hkl and <I(hkl)> is the average intensity [e] R = Σ hkl | |F obs | -|F calc | |/Σ hkl |F obs |, where R free is calculated without a sigma cut off for a randomly chosen 5% of reflections, which were not used for structure refinement, and R work is calculated for the remaining reflections [f] Deviations from ideal bond lengths/angles [g] Number of residues in favored region / allowed region / outlier region for SP1, SP4, SP5 and SP3 using cultivation of the E. coli DH10B strain ES16 with genes antABCDEFGH in standard growth medium (LB medium, 14 N , 12 C, 16 O, 1 H ), 15 N labeled medium ( 15 N , 12 C, 16 O, 1 H ), or 13 C labeled medium ( 14 N , 13 C, 16 O, 1 H ) as described previously. 31 
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